Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose

Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose

Study reveals Obicetrapib reduced bad cholesterol by over 30% in patients already on maximum therapy

A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. (iStock)

Low-density lipoprotein (LDL), which is sometimes called "bad cholesterol," is associated with negative health effects when present in high amounts. (iStock)

Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase the chances of a heart attack when it’s present in high levels in the blood. (iStock)

Obicetrapib was found to be "well-tolerated" by the participants, the researchers noted. (iStock)